Aggregate(@AggregateOA) 's Twitter Profile Photo

Early View💡
'Tracking interactions between and mediated by -induced proline production during evasion of HCC' by Ping Li & Bo Tang et al. Wiley Biomedical Science

Check👉doi.org/10.1002/agt2.5…

Early View💡
'Tracking interactions between #TAMs and #CAFs mediated by #arginase-induced proline production during #immune evasion of HCC' by Ping Li & Bo Tang et al. @WileyBiomedical #fibroblasts #macrophages #HepatocellularCarcinoma

Check👉doi.org/10.1002/agt2.5…
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

🔥MORPHEUS-Phase Ib/II Liver study: Tiragolumab in combination with AtezoBev in
👉Interesting signal of activity for anti-TIGIT 💊in (despite control arm 🤨), looking forward to IMbrave152/ SKYSCRAPER-14
ESMO - Eur. Oncology OncoAlert EASL Education EASL Education

🔥MORPHEUS-Phase Ib/II Liver study: Tiragolumab in combination with AtezoBev in #hepatocellularcarcinoma #ASCO23
👉Interesting signal of activity for anti-TIGIT 💊in #HCC (despite control arm 🤨), looking forward to IMbrave152/ SKYSCRAPER-14
@myESMO @OncoAlert @EASLedu @EASLedu
account_circle
Hepatoma Research(@HepatomaRes) 's Twitter Profile Photo

📢Original Article: Risk of development in long-term (t)ide analog suppressed patients with chronic
🎀Study objectives and endpoints
🎀Clinical outcomes
🎀PAGE-B score
🔗 Download: f.oaes.cc/xmlpdf/ea0a27d…

📢Original Article:  Risk of #hepatocellularcarcinoma development in long-term #nucles(t)ide analog suppressed patients with chronic #HepatitisB 
🎀Study objectives and endpoints
🎀Clinical outcomes
🎀PAGE-B score
🔗 Download: f.oaes.cc/xmlpdf/ea0a27d…
account_circle
Hao Yin(@HaoYin20) 's Twitter Profile Photo

(AGE)⏫liver matrix (Collagen bundle network with shorter fibers & smaller angles), but not


A mechanosensitive integrin β1–Tensin 1– cascade (⏫by high Viscoelasticity) ⏫

#AdvancedGlycationEndproduct (AGE)⏫liver matrix #Viscoelasticity (Collagen bundle network with shorter fibers & smaller angles), but not #Stiffness
#T2DM #NASH #MASH

A mechanosensitive integrin β1–Tensin 1–#YAP cascade (⏫by high Viscoelasticity) ⏫#HepatoCellularCarcinoma
account_circle
Frederick Chite MD(@ChiteDoc) 's Twitter Profile Photo

Thank you ESMO - Eur. Oncology for the invitation as Faculty in the just concluded ESMO Preceptorship on Liver Cancer – the first ESMO educational course held in Kenya!
It was such a pleasure and a great learning experience!

Thank you @myESMO for the invitation as Faculty in the just concluded ESMO Preceptorship on Liver Cancer – the first ESMO educational course held in Kenya!
It was such a pleasure and a great learning experience! #Quality #standardofcare #livercancer #hepatocellularcarcinoma
account_circle
Beau Bosko Toskich, MD FSIR(@BeauToskichMD) 's Twitter Profile Photo

+ + demonstrates superior PFS (23% reduced risk) when compared to alone for the treatment of .

Congratulations to the investigators. Welcome the era.🧩

astrazeneca.com/media-centre/p…

account_circle
Gustavo(@gusviani) 's Twitter Profile Photo

🎙️SBRT showed ⬆️local antitumoral activity for than TACE-DEB, w/o detrimental effects on OS, tox & QoL‼️ OncoAlert IJROBP - The Red Journal
📌Ph3 RCT: TACE-DEB ✖️ SBRT treatments for (HCC)
TACE-DEB : Max 4 procedures; ablation allowed after incomplete TACE-DEB

🎙️SBRT showed ⬆️local antitumoral activity for #HCC than TACE-DEB, w/o detrimental effects on OS, tox & QoL‼️ @OncoAlert @IJROBP 
📌Ph3 RCT: TACE-DEB ✖️ SBRT treatments for #hepatocellularcarcinoma (HCC) 
TACE-DEB : Max 4 procedures; ablation allowed after incomplete TACE-DEB
account_circle
Franklin(@MedicalFrank) 's Twitter Profile Photo

Happy to announce I'll be presenting our work on the changing treatment patterns for at the upcoming ASCO Medical Student & Resident Abstract Forum. Thank you Dana-Farber Division of Population Sciences and Chris Manz for the support on this important topic.

Happy to announce I'll be presenting our work on the changing treatment patterns for #HepatocellularCarcinoma at the upcoming @ASCO Medical Student & Resident Abstract Forum. Thank you @DFCIPopSci and @ChrisManzMD for the support on this important topic. #LiverTwitter #GItwitter
account_circle
CVIR Journal(@CVIR_Journal) 's Twitter Profile Photo

to 2022 ⬅️
Study Protocol: Adjuvant Holmium-166 After in Early-Stage Patients—A Dose-Finding Study (HORA EST HCC Trial)
link.springer.com/article/10.100…
🔓

#tb to 2022 ⬅️
Study Protocol: Adjuvant Holmium-166 #Radioembolization After #RadiofrequencyAblation in Early-Stage #HepatocellularCarcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)
link.springer.com/article/10.100…
#OpenAccess 🔓
account_circle
Pharmacological Research(@PharmacolRes) 's Twitter Profile Photo

Preclinical study showed that an ADAM17 inhibitor (ZLDI-8) sensitizes hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk: doi.org/10.1016/j.phrs…

Preclinical study showed that an ADAM17 inhibitor (ZLDI-8) sensitizes hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk: doi.org/10.1016/j.phrs…
#ADAM17 #hepatocellularcarcinoma #PharmacolRes #openaccess #Research #PharmaTwitter #MedTwitter
account_circle
Terasaki Institute for Biomedical Innovation(@TerasakiInst) 's Twitter Profile Photo

Scientists from the Terasaki Institute have developed an injectable or catheter-administered hydrogel with enhanced capabilities for treating hepatocellular carcinoma (HCC), a deadly form of liver cancer.
buff.ly/48aNeVE

Scientists from the Terasaki Institute have developed an injectable or catheter-administered hydrogel with enhanced capabilities for treating hepatocellular carcinoma (HCC), a deadly form of liver cancer.  
buff.ly/48aNeVE 

#TerasakiInstitute  #HepatoCellularCarcinoma
account_circle
JHEP Reports(@JHEP_Reports) 's Twitter Profile Photo

🟪New Article in press❕

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multi-center real world study with focus on bleeding and thromboembolic events

🔓 at 👉jhep-reports.eu/article/S2589-…



🟪New Article in press❕

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multi-center real world study with focus on bleeding and thromboembolic events

 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-…

#LiverTwitter
#HepatocellularCarcinoma
#HCC
account_circle